PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022Подробнее

177 Lu PSMA Treatment for Prostate Cancer (Update: FDA approved on 3/23/22)Подробнее

Lu-PSMA Radioligand TherapyПодробнее

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

Lutetium-177: PSMA Guided Treatment | #ProstateCancer | #MarkScholzMD | #PCRIПодробнее

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4Подробнее

Treatment, Imaging, & More | Q+A with Eugene Kwon, MD & Mark Moyad, MD | 2021 PCRI ConferenceПодробнее

Just the Beginning: What's Next for Radiotheranostics in Prostate Cancer?Подробнее

Appropriate Use of PSMA PET in Clinical PracticeПодробнее

Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient ConferenceПодробнее